• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Intake of fish fatty acids associated with lower risk of breast cancer

bys25qthea
June 29, 2013
in Chronic Disease, Obstetrics
Reading Time: 3 mins read
Intake of fish fatty acids associated with lower risk of breast cancer
Share on FacebookShare on Twitter

Image: PD

1. In a meta-analysis, higher consumption of dietary marine polyunsaturated fatty acids was associated with a lower risk of breast cancer. 

2. No beneficial association was found with either overall dietary fish intake or ALA intake (a non-marine polyunsaturated fatty acid). 

Evidence Rating Level: 1 (Excellent) 

Study Rundown: The major finding of this meta-analysis is a dose-dependent decrease in breast cancer risk with increasing consumption of marine n-3 polyunsaturated fatty acids (PUFAs). Although research in animal models suggests PUFAs have cancer-fighting properties, investigations of PUFAs and cancer risk in humans has been inconsistent.

This study is one of the first to quantify an overall and dose-dependent association between types of PUFA intake and breast cancer risk. Inclusion of only prospective studies in this systematic review mitigates many potential sources of bias. However, study findings are limited by lack of information on BMI, a demonstrated confounder, in many of the studies. Additional prospective investigation of the relationship between marine n-3 PUFA intake, BMI, and breast cancer risk is merited.

RELATED REPORTS

Cognitive behaviour therapy may be superior to bright light therapy for insomnia in women with breast cancer undergoing chemotherapy

Newer GLP-1 agents yield substantial weight loss in nondiabetic adults

Tumour microenvironment factors may influence cancer progression and response to tamoxifen (Nolvadex) in patients with estrogen receptor-positive and human epidermal growth factor receptor 2 breast cancer

Click to read the study in BMJ

Click to read an accompanying Press Release in BMJ

Relevant Reading: Uptodate: Fish oil and marine omega-3 fatty acids

In-Depth [systematic review and meta-analysis]: Researchers included English-language, prospective cohort studies evaluating the association between dietary intake of fish and n-3 polyunsaturated fatty acids (PUFAs) with the incidence of breast cancer in a systematic review and meta-analysis. In the cohort studies included, exposure levels were measured using both dietary intake and tissue biomarkers and classified by type of n-3 PUFA intake, specifically dietary fish, marine n-3 PUFAs or non-marine PUFAs.

Overall, 26 publications met inclusion criteria, representing a total of 20,905 cases of breast cancer and 883,585 participants studied. Among the 17 articles evaluating the association of marine n-3 PUFA and breast cancer, n-3 PUFA intake was associated with a 14% decreased risk of breast cancer (RR=0.86, 95% CI=0.78-0.94). This effect estimate was more pronounced in models adjusted for BMI (0.74, 0.64-0.86) compared to those that were not (0.90, 0.80-1.01). Eight articles were eligible for dose-response analysis, which documented a 0.1g/day increase in dietary marine n-3 PUFA was associated with a 5% lower risk of breast cancer (0.95, 0.90-1.00). No association was found for overall fish intake or ALA exposure. 

By Maren Shapiro and Leah Hawkins, MD, MPH

More from this author: USPSTF recommends chemoprevention for women at high risk for breast cancer, IUD contraception equally safe in teenagers as in older women, Black men less likely to receive follow-up for elevated prostate cancer marker, PSA,  More U.S. women using emergency contraception pill, No-cost contraception reduces unintended pregnancies

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. Content is produced in accordance with fair use copyrights solely and strictly for the purpose of teaching, news and criticism. No benefit, monetary or otherwise, is realized by any participants or the owner of this domain. 

Tags: BMIBreast Cancercancerfatty acidsPUFAs
Previous Post

Rho kinase inhibitor safely reduces intraocular pressure

Next Post

2 Minute Medicine Rewind June 24 – June 30

RelatedReports

Sleep duration, sleepiness, chronotype have variable associations with teen self-regulation
Chronic Disease

Cognitive behaviour therapy may be superior to bright light therapy for insomnia in women with breast cancer undergoing chemotherapy

September 3, 2026
Increasing maternal BMI linked to higher risk of cerebral palsy
Endocrinology

Newer GLP-1 agents yield substantial weight loss in nondiabetic adults

August 31, 2026
Variability in interpretation of breast biopsy slides associated with low verification of atypia and ductal carcinoma in situ
Chronic Disease

Tumour microenvironment factors may influence cancer progression and response to tamoxifen (Nolvadex) in patients with estrogen receptor-positive and human epidermal growth factor receptor 2 breast cancer

August 13, 2026
Sleep duration, sleepiness, chronotype have variable associations with teen self-regulation
Weekly Rewinds

2 Minute Medicine Rewind August 10, 2026

August 10, 2026
Next Post
Emerging coronavirus found to spread in healthcare facilities

2 Minute Medicine Rewind June 24 - June 30

Study shows poor follow up of children with high blood pressure

Study shows poor follow up of children with high blood pressure

Pediatric chronic pain patients typically Caucasian, female adolescents.

Pediatric chronic pain patients typically Caucasian, female adolescents.

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • 2MM: AI Roundup: FDA clears autonomous blood draw robot, UHS acquires Talkspace, Databricks reaches $190 billion valuation, and AI-designed glioblastoma vaccine advances
  • Aletta brings autonomous robotics into routine blood collection
  • Higher coffee intake is associated with lower visceral fat despite similar body mass index
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.

2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in